- Td booster every 10 years for adults
- Two doses (0-6 month schedule). Females only.
More information available at:
https://www.dgs.pt/publicacoes/livro-azul-de-vacinas-programa-nacional-de-vacinacao-e-outras-estrategias-de-imunizacao.aspx
MAJOR HISTORICAL CHANGES
Jan.2017: laucnh of the 2017 national vaccination programme. see modifications at http://www.dgs.pt/?ci=923&ur=1&newsletter=374
BCG:
2017: recommended only to specific risk-groups. previously universal vaccination
Measles, mumps and rubella:
1973-77: Vaccination campaign with measles monovalent vaccine to 1-4 years old children.
1974: Measles monovalent vaccine introduced in the national childhood vaccination programme and recommended at 12 to 24 months of age.
1987: Combined measles, mumps and rubella vaccine (MMR) introduced in the national childhood vaccination programme and recommended at 15 months of age.
1990: Second MMR dose added and recommended at 11-13 years of age.
2000: Recommended age for second MMR lowered to 5-6 years of age.
2012: First dose lowered to 12 months of age
HPV:
2008: 27 October. HPV vaccination introduced in national vaccination schedule for 13-year-old girls.
2009: January. HPV vaccination catch-up campaign lasting till 2011, for 17-year old girls.
2012: routine vaccination at 13 years.
2014: HPV schedule changed to 2 doses at 10-13 years old (since oct 2014)
2017: HPV nonavalent introduced as a 2 doses schedule for females at age 10
2020: vaccination extended to boys born from 2009
Meningococcal disease
Men C:
2012: one dose at 12 months instead of a 3-dose schedule
Men B:
2020: introduced as a 3-dose schedule for children born from 2019
Pneumococcal Disease:
2015: PCV 13 included at 2, 4 and 12 months old (since jul 2015)
Td: Adult booster
2017: Vaccination at 25, 45 and 65 years of age and thereafter every 10 years
TdaP: Vaccination during pregnancy
2017: to be given at each pregnancy between gestation week 20 to 36.
________________________________________________________________________
Date of last update: 5 February 2026
________________________________________________________________________